Multiply Labs is a physical AI company building the manufacturing infrastructure for the next generation of medicine. Built on the belief that physical AI can be as impactful for drug manufacturing as digital AI is for drug discovery, Multiply Labs has created robotic clusters that automate the manual, error-prone steps of biologics manufacturing across cell and gene therapies, antibodies, viral vectors, and mRNA therapies, helping companies manufacture these therapies with greater speed, consistency, and scale. Rather than operating as an outsourced manufacturing service, each cluster is owned and operated by the pharmaceutical company itself, keeping production, data, and supply chain fully in-house.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/07/26	$75,000,000	Series B	AstraZeneca Casdin Capital Fifty Years Founders Fund Lingotto Investment Management Lux Capital NantWorks Ora Global Strange Ventures Teradyne Robotics Ventures	undisclosed